396 Results

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Pao
    Pao
  4. Ladanyi
    Ladanyi
  5. O'Reilly
    O'Reilly
  6. Miller
    Miller
  7. Yu
    Yu
  8. Abou-Alfa
    Abou-Alfa
  9. Zakowski
    Zakowski
  10. Lacouture
    Lacouture

Groups

  1. Department of Medicine (237)
  2. Solid Tumor Oncology Division (203)
  3. Thoracic Oncology (97)
  4. GSK Faculty (87)
  5. Gastrointestinal Oncology Service (74)
  6. Tow Center for Developmental Oncology (TCDO) (70)
  7. Human Oncology and Pathogenesis Program (65)
  8. Department of Pathology and Laboratory Medicine (64)
  9. Center for Pancreatic Cancer Research (43)
  10. Surgery (43)
  1. "erlotinib"
Formats
  1. Journal Article (362)
  2. Review (16)
  3. Meeting Abstract (7)
  4. Conference Paper (4)
  5. Book Section (2)
  6. Editorial (2)
  7. Guidelines (2)
  8. Correspondence (1)
Groups
  1. Department of Medicine (237)
  2. Solid Tumor Oncology Division (203)
  3. Thoracic Oncology (97)
  4. GSK Faculty (87)
  5. Gastrointestinal Oncology Service (74)
  6. Tow Center for Developmental Oncology (TCDO) (70)

More Groups

People
  1. Mark Kris (53)
  2. Gregory Riely (51)
  3. Vincent Miller (45)
  4. William Pao (42)
  5. Marc Ladanyi (41)
  6. Eileen O'Reilly (28)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (6)
  6. 2020 (7)

More Years

Publications
  1. Clinical Cancer Research (35)
  2. Journal of Thoracic Oncology (33)
  3. Journal of Clinical Oncology (23)
  4. Cancer (12)
  5. Journal of the National Comprehensive Cancer Network (11)
  6. Supportive Care in Cancer (8)

More Publications

Publishers
  1. Elsevier Inc. (77)
  2. American Association for Cancer Research (45)
  3. American Society of Clinical Oncology (26)
  4. Oxford University Press (21)
  5. Springer (21)
  6. Wiley Blackwell (21)

More Publishers

Results (396)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer
    Journal Article

    Herbst, R. S.; Prager, D.; Hermann, R.; Fehrenbacher, L.; Johnson, B. E.; Sandler, A.; Kris, M. G.; Tran, H. T.; Klein, P.; Li, X.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • New agents for the treatment of ovarian cancer: The next generation
    Journal Article

    Dupont, J.; Aghajanian, C.; Sabbatini, P.; Spriggs, D. R.
    International Journal of Gynecological Cancer (2005)

    Fulltext@MSK | Save
  • New frontiers in translational research in neuro-oncology and the blood-brain barrier: Report of the Tenth Annual Blood-brain Barrier Disruption Consortium Meeting
    Journal Article

    Doolittle, N. D.; Abrey, L. E.; Bleyer, W. A.; Brem, S.; Davis, T. P.; Dore-Duffy, P.; Drewes, L. R.; Hall, W. A.; Hoffman, J. M.; Korfel, A.; more...
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Antibody-based therapies for colorectal cancer
    Journal Article

    Chung, K. Y.; Saltz, L. B.
    The Oncologist (2005)

    Fulltext@MSK | Save
  • Society of Urologic Oncology position statement: Redefining the management of hormone-refractory prostate carcinoma
    Journal Article

    Chang, S. S.; Benson, M. C.; Campbell, S. C.; Crook, J.; Dreicer, R.; Evans, C. P.; Hall, M. C.; Higano, C.; Kelly, W. K.; Sartor, O.; more...
    Cancer (2005)

    Fulltext@MSK | Save
  • Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases
    Journal Article

    Carter, T. A.; Wodicka, L. M.; Shah, N. P.; Velasco, A. M.; Fabian, M. A.; Treiber, D. K.; Milanov, Z. V.; Atteridge, C. E.; Biggs, W. H. 3rd; Edeen, P. T.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2005)

    Fulltext@MSK | Save
  • Current issues in Wilms tumor management
    Journal Article

    Grundy, P.; Perlman, E.; Rosen, N. S.; Warwick, A. B.; Bender, J. G.; Ehrlich, P.; Hoffer, F. A.; Lee, N. D.
    Current Problems in Cancer (2005)

    Fulltext@MSK | Save
  • Maximizing the potential of bevacizumab in cancer treatment
    Journal Article

    Bergsland, E.; Dickler, M. N.
    The Oncologist (2004)

    Fulltext@MSK | Save
  • Molecular biology of gliomas
    Journal Article

    Lassman, A. B.
    Current Neurology and Neuroscience Reports (2004)

    Fulltext@MSK | Save
  • EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib
    Journal Article

    Pao, W.; Miller, V.; Zakowski, M.; Doherty, J.; Politi, K.; Sarkaria, I.; Singh, B.; Heelan, R.; Rusch, V.; Fulton, L.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2004)

    Fulltext@MSK | Save